A stevia-derived sweetener could improve hair loss treatment Updated on: November 01,2025 A stevia-derived sweetener could improve hair loss treatment Updated on:November 01,2025
Low-cost ketamine treatment for depression found to be effective long term Updated on: November 01,2025 Low-cost ketamine treatment for depression found to be effective long term Updated on:November 01,2025
Novel drug combination offers hope for men with advanced prostate cancer Updated on: November 02,2025 Novel drug combination offers hope for men with advanced prostate cancer Updated on:November 02,2025
FDA approves Zoryve for atopic dermatitis in young children Updated on: November 02,2025 FDA approves Zoryve for atopic dermatitis in young children Updated on:November 02,2025
AI tool designed to identify buyer behavior reimagined to discover medicine safety and repurposing opportunities Updated on: November 02,2025 AI tool designed to identify buyer behavior reimagined to discover medicine safety and repurposing opportunities Updated on:November 02,2025
Study finds dosing concerns for common anticoagulant in underserved areas Updated on: November 02,2025 Study finds dosing concerns for common anticoagulant in underserved areas Updated on:November 02,2025
Bispecific inhibitor can combat a wide range of coronaviruses, including Paxlovid-resistant variants Updated on: November 02,2025 Bispecific inhibitor can combat a wide range of coronaviruses, including Paxlovid-resistant variants Updated on:November 02,2025
Drug discovery platform yields optimized compound against SARS-CoV-2 and shows promise against other RNA-based viruses Updated on: November 02,2025 Drug discovery platform yields optimized compound against SARS-CoV-2 and shows promise against other RNA-based viruses Updated on:November 02,2025
Study of 86 chikungunya outbreaks reveals unpredictability in size and severity Updated on: November 02,2025 Study of 86 chikungunya outbreaks reveals unpredictability in size and severity Updated on:November 02,2025
FDA clears heart tissue regeneration drug AD-NP1 for clinical trials Updated on: November 02,2025 FDA clears heart tissue regeneration drug AD-NP1 for clinical trials Updated on:November 02,2025